NBC News

Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for ...
Reuters

Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug ...
FierceBiotech

Apricus Biosciences Appoints Manufacturer for Vitaros®, Its Newly Approved Drug to Treat Erectile Dysfunction in Canada

SAN DIEGO--(BUSINESS WIRE)-- Apricus Biosciences, Inc. (“Apricus Bio”) (NASDAQ: APRI), announced today that it has appointed a manufacturer for Vitaros ®, its new treatment for erectile dysfunction ...
NBC News

Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East

SAN DIEGO and DUBAI, United Arab Emirates, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) and Elis Pharmaceuticals ("Elis"), announced today that the two ...
FierceBiotech

Apricus Biosciences to File for Market Authorization to Sell Vitaros® for Erectile Dysfunction in Latin America

My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about APRI -- Potential Market Size for Vitaros® for Erectile Dysfunction in ...